Naoki Katase

Nagasaki, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 42 publications

Attempt to control head and neck cancer through medium-molecular weight drug discovery.

Attempt to control head and neck cancer through medium-molecular weight drug discovery.

Journal: Journal of oral biosciences

Published: December 23, 2025

Supernatants from DNase-deficient Prevotella intermedia strains enhance oral squamous cell carcinoma cell migration and invasion by activating inflammatory and epithelial-mesenchymal transition pathways.

Supernatants from DNase-deficient Prevotella intermedia strains enhance oral squamous cell carcinoma cell migration and invasion by activating inflammatory and epithelial-mesenchymal transition pathways.

Journal: Biochemical and biophysical research communications

Published: November 14, 2025

Differentially Expressed Genes in Head and Neck Squamous Cell Carcinoma: Exploratory Research Using the Cancer Genome Atlas (TCGA) RNA Sequence Data and DESeq2 Package.

Differentially Expressed Genes in Head and Neck Squamous Cell Carcinoma: Exploratory Research Using the Cancer Genome Atlas (TCGA) RNA Sequence Data and DESeq2 Package.

Journal: Cureus

Published: October 14, 2025

Comparison of the Anticancer Effects of a Complementary Peptide for Dickkopf WNT Signaling Pathway Inhibitor 3 (DKK3) With Conventional Anticancer Drugs in the Treatment of Oral Squamous Cell Carcinoma: A Pilot Study.

Comparison of the Anticancer Effects of a Complementary Peptide for Dickkopf WNT Signaling Pathway Inhibitor 3 (DKK3) With Conventional Anticancer Drugs in the Treatment of Oral Squamous Cell Carcinoma: A Pilot Study.

Journal: Cureus

Published: September 04, 2025

Histological Findings of Oral Epithelial Dysplasia and DKK3 Expression That Can Predict Future Progression to Oral Squamous Cell Carcinoma.

Histological Findings of Oral Epithelial Dysplasia and DKK3 Expression That Can Predict Future Progression to Oral Squamous Cell Carcinoma.

Journal: Oral diseases

Published: June 30, 2025

Carbon ion radiotherapy and AI chemotherapy for soft tissue sarcoma of the temporomandibular joint: A case report of 5-year disease-free survival without wide resection.

Carbon ion radiotherapy and AI chemotherapy for soft tissue sarcoma of the temporomandibular joint: A case report of 5-year disease-free survival without wide resection.

Journal: Journal of stomatology, oral and maxillofacial surgery

Published: June 03, 2025

Giant dedifferentiated liposarcoma of the mandible.

Giant dedifferentiated liposarcoma of the mandible.

Journal: International journal of oral and maxillofacial surgery

Published: April 25, 2025

A Case Report of Primary Intraosseous Carcinoma of the Mandible Initially Diagnosed as Mandibular Osteomyelitis.

A Case Report of Primary Intraosseous Carcinoma of the Mandible Initially Diagnosed as Mandibular Osteomyelitis.

Journal: Cureus

Published: February 12, 2025

DKK3 expression is correlated with poorer prognosis in head and neck squamous cell carcinoma: A bioinformatics study based on the TCGA database.

DKK3 expression is correlated with poorer prognosis in head and neck squamous cell carcinoma: A bioinformatics study based on the TCGA database.

Journal: Journal of oral biosciences

Published: August 18, 2023

EpEX, the soluble extracellular domain of EpCAM, resists cetuximab treatment of EGFR-high head and neck squamous cell carcinoma.

EpEX, the soluble extracellular domain of EpCAM, resists cetuximab treatment of EGFR-high head and neck squamous cell carcinoma.

Journal: Oral oncology

Published: March 13, 2023

Establishment of anti-DKK3 peptide for the cancer control in head and neck squamous cell carcinoma (HNSCC).

Establishment of anti-DKK3 peptide for the cancer control in head and neck squamous cell carcinoma (HNSCC).

Journal: Cancer cell international

Published: September 21, 2022

Inhibition of pancreatic cancer-cell growth and metastasis in vivo by a pyrazole compound characterized as a cell-migration inhibitor by an in vitro chemotaxis assay.

Inhibition of pancreatic cancer-cell growth and metastasis in vivo by a pyrazole compound characterized as a cell-migration inhibitor by an in vitro chemotaxis assay.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: July 19, 2022

Showing 1-12 of 42

Last Updated: 09/26/2026